EXG110 injection

DRUG2 trials

Sponsors

The Children's Hospital of Zhejiang University School of Medicine, Hangzhou Jiayin Biotech Ltd

Conditions

Fabry Disease

Phase 1

The Safety and Efficacy of Intravenous EXG110 in Patients With Fabry Disease

Not yet recruitingNCT06819514

Hangzhou Jiayin Biotech LtdFabry Disease

Start: 2025-03-01End: 2028-03-15Target: 16Updated: 2025-02-11

Unknown Phase

Evaluate the Safety and Preliminary Efficacy of EXG110 in Subjects With Fabry Disease

RecruitingNCT06539624

The Children's Hospital of Zhejiang University School of MedicineFabry Disease

Start: 2024-10-16End: 2027-04-09Target: 12Updated: 2026-02-27